Gemcitabine Induced Pulmonary Toxicity With Late Onset

Nuri Tutar; Hakan Buyukoglan; İnci Gülmez; Fatma Sema Oymak; Ramazan Demir

Gemcitabine Induced Pulmonary Toxicity With Late Onset

Yıl 2012, Cilt: 9 Sayı: 3, - , 01.09.2012

Nuri Tutar Hakan Buyukoglan İnci Gülmez Fatma Sema Oymak Ramazan Demir

Öz

Gemcitabine is a nucleoside analog that has been increasingly used in the chemotherapy of solide tumors, including breast, pancreas ovary and non small cell lung cancer. It is generally well tolerated and has few side effects. Gemcitabine induced pulmonary complications range from mild dyspnea to death from ARDS. A 57- year- old man was treated with six cycles of gemcitabine because of pancreatic carcinoma in July, 2004.The patient had self limiting weakness, lack of appetite, nausea and no dyspnea in treatment period. One year later, he was admitted to a local hospital with exercises induced dyspnea. He had been given levofloxacin for 14 days. On admission to our hospital, his complaint kept on. A few inspiratory crackles were present at right base. CXR demonstrated interstitial infiltrations in the right lung lower zone. HRCT showed grand glass opacity and mild reticular patterns in right lung middle and lower lobes. Bronchoscopy was performed. Transbronchial biopsy revealed nonspecific interstitial pneumonia. Following the administration of oral corticosteroid, he had complete resolution of all signs and symptoms of gemcitabine toxicity. Key words: Gemcitabine, nonspecific interstitial pneumonia, drug toxicity

Anahtar Kelimeler

-

Kaynakça

Aapro MS,Martin C,Hatty S. Gemcitabine-a safety review. Anticancer Drugs 1998;9:191-201.
Vander EIs NJ,Miller V. Succesful treatment of gem- citabine toxicity with a brief course of oral corticosteroid therapy. Chest 1998;114(6):1779-81.
Maniwa K,Tanaka E, et al. An autopsy case of acute pul- monary toxicity associated with Gemcitabine. Intern Med 2003;42(10):1022-5.
Joerger M,Gunz A,Speich R,Pestolazzi BC. Gemcitabine related pulmoner toxicity:case series. Swiss Med Wkly 2002;132(1-2):17-20
Pavlakis N,Bell DR,Millward MJ,Levi JA. Fatal pulmonary toxicity resulting from treatment with Gemcitabine. Cancer 1997;80(2):286-91.
Sabria-Trias J,Bonnaud F,Sioniac M. Severe interstitial pneumonitis related to Gemcitabine. Rev Mal Respir 2002;19(5 Pt 1):645-7.
Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS; American College of Physicians. Lung cancer. Special treatment issues. Chest 2003;123(1 Suppl):244S-58S.
Hammer V,Schmitz N,Pauli G,Quoix E.Interstitial lung dis- ease in a patient given Gemcitabine. Rev Pneumol Clin. 2002;58(1):23-6.
Linskens RK,Golding RP,Van Groeningen CS,Giaccone G. Severe acute lung injury induced by gemcitabine. Neth J Med 2000;56(6):232-5.
Rosado MF,Kett DH,Schein RM,Baraona FJ,Sridhar KS. Severe pulmonary toxicity in a patient treated with gem- citabine. Am J Clin Oncol 2002;25(1):31-3.
Boisella PM,Morrin MM,Huberman MS. Gemcitabine pul- monary toxicity: CT features. J Comput Assist Tomogr 2000;24(6):977-80.